<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Medications for daytime sleepiness in individuals with idiopathic hypersomnia - Trotti, LM - 2021 | Cochrane Library</title> <meta content="Medications for daytime sleepiness in individuals with idiopathic hypersomnia - Trotti, LM - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012714.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Medications for daytime sleepiness in individuals with idiopathic hypersomnia - Trotti, LM - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012714.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012714.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Medications for daytime sleepiness in individuals with idiopathic hypersomnia" name="citation_title"/> <meta content="Lynn M Trotti" name="citation_author"/> <meta content="Emory University School of Medicine" name="citation_author_institution"/> <meta content="lbecke2@emory.edu" name="citation_author_email"/> <meta content="Lorne A Becker" name="citation_author"/> <meta content="SUNY Upstate Medical University" name="citation_author_institution"/> <meta content="Catherine Friederich Murray" name="citation_author"/> <meta content="Hypersomnia Foundation" name="citation_author_institution"/> <meta content="Romy Hoque" name="citation_author"/> <meta content="Emory University School of Medicine" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD012714.pub2" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/05/25" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012714.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012714.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012714.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Bias; Clarithromycin [*therapeutic use]; Disorders of Excessive Somnolence [*drug therapy, etiology]; Idiopathic Hypersomnia [*complications]; Modafinil [*therapeutic use]; Placebos [therapeutic use]; Quality of Life; Randomized Controlled Trials as Topic; Wakefulness; Wakefulness-Promoting Agents [*therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012714.pub2&amp;doi=10.1002/14651858.CD012714.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="IregKd2C";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012714\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012714\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","th","ko","ms","ja","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012714.pub2",title:"Medications for daytime sleepiness in individuals with idiopathic hypersomnia",firstPublishedDate:"May 25, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Epilepsy Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=IregKd2C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012714.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012714.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012714.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012714.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012714.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012714.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012714.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012714.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012714.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012714.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3079 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012714.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#CD012714-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#CD012714-sec-0074"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#CD012714-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#CD012714-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#CD012714-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#CD012714-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#CD012714-sec-0042"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#CD012714-sec-0068"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/appendices#CD012714-sec-0079"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/table_n/CD012714StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/table_n/CD012714StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Medications for daytime sleepiness in individuals with idiopathic hypersomnia</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/information#CD012714-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Lynn M Trotti</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/information#CD012714-cr-0005">Lorne A Becker</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/information#CD012714-cr-0006">Catherine Friederich Murray</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012714.pub2/information#CD012714-cr-0007">Romy Hoque</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/information/en#CD012714-sec-0085">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 25 May 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012714.pub2">https://doi.org/10.1002/14651858.CD012714.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012714-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012714-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012714-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012714-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012714-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD012714-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD012714-abs-0004">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012714-abs-0001" lang="en"> <section id="CD012714-sec-0001"> <h3 class="title" id="CD012714-sec-0001">Background</h3> <p>Idiopathic hypersomnia is a disorder of excessive daytime sleepiness, often accompanied by long sleep times or pronounced difficulty in awakening, in the absence of a known cause. The optimal treatment strategy for idiopathic hypersomnia is currently unknown. </p> </section> <section id="CD012714-sec-0002"> <h3 class="title" id="CD012714-sec-0002">Objectives</h3> <p>To assess the effects of medications for daytime sleepiness and related symptoms in individuals with idiopathic hypersomnia and, in particular, whether medications may: 1. reduce subjective measures of sleepiness; 2. reduce objective measures of sleepiness; 3. reduce symptoms of cognitive dysfunction; 4. improve quality of life; and 5. be associated with adverse events. </p> </section> <section id="CD012714-sec-0003"> <h3 class="title" id="CD012714-sec-0003">Search methods</h3> <p>We searched the following databases on 4 February 2021: Cochrane Register of Studies (CRS Web), MEDLINE (Ovid, 1946 to 1 February 2021), and reference lists of articles. CRS Web includes randomized or quasi‐randomized controlled trials from PubMed, Embase, ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP), the Cochrane Central Register of Controlled Trials (CENTRAL), and the specialized registers of Cochrane Review Groups, including the Cochrane Epilepsy Group. We previously searched the WHO ICTRP separately when loading of ICTRP records into CRS Web was temporarily suspended. </p> </section> <section id="CD012714-sec-0004"> <h3 class="title" id="CD012714-sec-0004">Selection criteria</h3> <p>Randomized studies comparing any medication to placebo, another medication, or a behavioral intervention. </p> </section> <section id="CD012714-sec-0005"> <h3 class="title" id="CD012714-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data and assessed trial quality. We contacted study authors for additional data. We collected data on adverse events from the included trials. </p> </section> <section id="CD012714-sec-0006"> <h3 class="title" id="CD012714-sec-0006">Main results</h3> <p>We included three trials, with a total of 112 participants. Risk of bias was low for the included studies. Two pharmaceutical company‐sponsored trials compared modafinil with placebo, involving 102 participants, nearly all of whom had idiopathic hypersomnia without long sleep time. Modafinil significantly improved self‐reported sleepiness on the Epworth Sleepiness Scale by 5.08 points more than placebo (95% confidence interval (CI) 3.01 to 7.16; 2 studies, 101 participants; high‐certainty evidence). Modafinil also significantly improved disease severity on the Clinical Global Impression of Severity scale by 1.02 points (95% CI 0.11 to 1.93; 1 study, 30 participants; moderate‐certainty evidence) and resulted in a greater proportion of participants who were "much improved" or "very much improved" on the Clinical Global Impression of Change (odds ratio (OR) for improvement 5.14, 95% CI 1.76 to 15.00; 1 study, 70 participants; moderate‐certainty evidence). Ability to remain awake on the Maintenance of Wakefulness Test was significantly improved with modafinil, by 4.74 minutes more than with placebo (95% CI 2.46 to 7.01; 2 studies, 99 participants; high‐certainty evidence). Ratings of exhaustion and effectiveness/performance were improved with modafinil compared to placebo in one study. Number of naps per week was no different between modafinil and placebo across two studies. Participants receiving modafinil experienced more side effects, although the difference did not reach statistical significance (OR 1.68, 95% CI 0.28 to 9.94; 2 studies, 102 participants; low‐certainty evidence). </p> <p>One trial studying 20 participants with different disorders of sleepiness included 10 participants with idiopathic hypersomnia, with or without long sleep time, and compared clarithromycin to placebo. We only included the subset of trial data for those participants with idiopathic hypersomnia, per our protocol. There were no significant differences between clarithromycin and placebo for the Epworth Sleepiness Scale, psychomotor vigilance testing, sleep inertia, other subjective ratings, or side effects. </p> </section> <section id="CD012714-sec-0007"> <h3 class="title" id="CD012714-sec-0007">Authors' conclusions</h3> <p>Modafinil is effective for the treatment of several aspects of idiopathic hypersomnia symptomatology, based on studies predominantly including participants with idiopathic hypersomnia without long sleep times, with low risk of bias, and evidence certainty ranging from high to low. There is insufficient evidence to conclude whether clarithromycin is effective for the treatment of idiopathic hypersomnia. There is a clear need for additional studies testing interventions for the treatment of idiopathic hypersomnia. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012714-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012714-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012714-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012714-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012714-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD012714-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD012714-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012714-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD012714-abs-0014">Polski</a> </li> <li class="section-language"> <a class="" href="full/th#CD012714-abs-0005">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD012714-abs-0003">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012714-abs-0002" lang="en"> <h3>Medications for daytime sleepiness in individuals with idiopathic hypersomnia</h3> <p><b>Review question</b><br/>We reviewed the evidence for the effects of different medications on daytime sleepiness in people with idiopathic hypersomnia. </p> <p><b>Background</b><br/>We wanted to know which medications are helpful for treating people with idiopathic hypersomnia, a disease that causes severe daytime sleepiness, and can sometimes cause people to sleep for very long amounts of time and have difficulty waking up and thinking or concentrating. It is called 'idiopathic' hypersomnia because the cause or causes of the disease are currently unknown. We wanted to find out which medications help with daytime sleepiness and other symptoms of the disease. We looked for studies testing any medication for idiopathic hypersomnia compared to a placebo (dummy pill) or another treatment. </p> <p><b>Search date</b><br/>The evidence is current to February 2021. </p> <p><b>Study characteristics</b><br/>We identified three studies. Two studies tested modafinil, and one study tested clarithromycin. </p> <p>The two studies testing modafinil included a total of 102 people with idiopathic hypersomnia. Most of these people slept fewer than 10 hours per night. Both studies included people from multiple sleep clinics. One study took place in Germany, and the other in Japan. Both studies compared modafinil to placebo, lasted for three weeks, and were funded by pharmaceutical companies with commercial interest in the results of the studies. </p> <p>The study testing clarithromycin included a total of 20 participants, from a single sleep clinic in the USA, 10 of whom had idiopathic hypersomnia. We only included information for the 10 people with idiopathic hypersomnia in the review. This study compared clarithromycin to placebo. Although the study lasted five weeks, we only included information from the first two weeks. This study was funded by the American Academy of Sleep Medicine Foundation, a charitable organization. </p> <p><b>Key results</b><br/>Modafinil improves sleepiness and the ability to stay awake during testing in a sleep laboratory. It probably improves the overall severity of idiopathic hypersomnia, feelings of exhaustion, and daytime performance. Modafinil may cause headaches and stomach symptoms such as nausea. </p> <p>It is uncertain whether or not clarithromycin helps with daytime sleepiness or other symptoms of idiopathic hypersomnia. It is uncertain whether there is a difference in side effects between clarithromycin and placebo, based on the information included in this review. </p> <p><b>Quality of the evidence</b><br/>We judged the overall quality of the evidence in the three studies as ranging from high to low, depending on the outcome and drug being studied. All three studies were well‐conducted. The studies were small. We found very few studies testing medication treatments for idiopathic hypersomnia. More studies are needed before we can be certain which medications are best for treating people with idiopathic hypersomnia. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012714-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012714-sec-0074"></div> <h3 class="title" id="CD012714-sec-0075">Implications for practice</h3> <section id="CD012714-sec-0075"> <p>There are limited data to guide treatment decisions for people with idiopathic hypersomnia. The existing data are strongest in support of modafinil, which is beneficial for key symptoms. In cases in which modafinil is insufficient to control symptoms or results in problematic side effects, the current data do not define which treatment should be considered as second line, therefore a number of different options may be reasonable based on clinical judgement. </p> </section> <h3 class="title" id="CD012714-sec-0076">Implications for research</h3> <section id="CD012714-sec-0076"> <p>There is a large unmet need for data to guide treatment decisions in people with idiopathic hypersomnia, and additional randomized controlled trials of a variety of interventions are needed. There are currently more ongoing than published trials for this disorder, so it is likely that clinical practice for this disorder may change in the coming years, as these additional trials are completed. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012714-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012714-sec-0008"></div> <div class="table" id="CD012714-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Modafinil compared to placebo for idiopathic hypersomnia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Modafinil compared to placebo for idiopathic hypersomnia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> idiopathic hypersomnia<br/><b>Setting:</b> outpatient<br/><b>Intervention:</b> modafinil<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What occurs</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Without modafinil</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With modafinil</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Epworth Sleepiness Scale (ESS), week 3<br/>№ of participants: 101<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean ESS at week 3 without modafinil was 15.0.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 5.08 points lower (3.01 lower to 7.16 lower)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modafinil reduces sleepiness as measured by ESS scores.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of naps/week, week 3<br/>№ of participants: 99<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean number of naps/week, week 3 without modafinil was 7.0 naps.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.0 fewer naps<br/>(5.5 fewer to 1.5 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modafinil may reduce the number of naps per week.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical Global Impression ‐ Severity (CGI‐S), change from baseline<br/>№ of participants: 30<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean CGI‐S change from baseline without modafinil was −0.36 points.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 1.02 points lower<br/>(1.93 lower to 0.11 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modafinil probably improves CGI‐S scores.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical Global Impression ‐ Change (CGI‐C), proportion much improved or very much improved at week 3 </p> <p>№ of participants: 70</p> <p>(1 RCT)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 5.14 (1.76 to 15.00)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18.9%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54.5%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35.6% more</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modafinil probably increases the proportion of people who are much improved or very much improved on the CGI‐C. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maintenance of Wakefulness Test (MWT), week 3<br/>№ of participants: 99<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean MWT at week 3 without modafinil was 8.9 minutes.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 4.74 minutes higher<br/>(2.46 higher to 7.01 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modafinil improves the amount of time that participants are able to remain awake during the MWT. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Effectiveness/performance, week 3<br/>№ of participants: 31<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean effectiveness/performance, week 3 without modafinil was 3.28 points.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.68 points lower<br/>(1.26 lower to 0.1 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modafinil probably improves ratings of effectiveness/performance.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of participants with any adverse events<br/>№ of participants: 102<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>OR 1.68 (0.28 to 9.94)</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Modafinil may result in more adverse events.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37.3%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56.9%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.6% more<br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>OR:</b> odds ratio; <b>RCT</b>: randomized controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by two levels for very serious imprecision: confidence interval includes the possibility of harm.<br/><sup>2</sup>Downgraded by one level for imprecision: wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012714-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Clarithromycin compared to placebo for idiopathic hypersomnia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Clarithromycin compared to placebo for idiopathic hypersomnia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> idiopathic hypersomnia<br/><b>Setting:</b> outpatient<br/><b>Intervention:</b> clarithromycin<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What occurs</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Without clarithromycin</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With clarithromycin</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Epworth Sleepiness Scale (ESS), change from baseline<br/>№ of participants: 10<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean ESS change from baseline without clarithromycin was −1.75 points.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.5 points lower<br/>(5.04 lower to 4.04 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There might be little or no reduction in sleepiness as measured by ESS scores.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stanford Sleepiness Scale (SSS), change from baseline<br/>№ of participants: 10<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean SSS change from baseline without clarithromycin was −1.25 points.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.33 points lower<br/>(2 lower to 1.34 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There might be little or no reduction in sleepiness as measured by SSS scores.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Average nocturnal sleep time from sleep diary, weeks 1 and 2<br/>№ of participants: 10<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean average nocturnal sleep time from sleep diary weeks 1 and 2 without clarithromycin was 462.0 minutes. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 79.7 minutes lower<br/>(171.7 lower to 12.4 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There might be little or no reduction in nocturnal sleep time as measured by sleep diary. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty waking in the morning, average of weeks 1 and 2<br/>№ of participants: 10<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean difficulty waking in the morning average of weeks 1 and 2 without clarithromycin was 5.67 points. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.31 points higher<br/>(2 lower to 2.62 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There might be little or no improvement difficulty waking in the morning as measured by sleep diary. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychomotor vigilance task (PVT) reciprocal of reaction time, change from baseline<br/>№ of participants: 10<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean PVT reciprocal of reaction time change from baseline without clarithromycin was 0.32. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.51 lower<br/>(1.19 lower to 0.17 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There might be little or no change in simple reaction times as measured by PVT reciprocal of reaction time. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functional Outcomes of Sleep Questionnaire (FOSQ), change from baseline<br/>№ of participants: 10<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean FOSQ change from baseline without clarithromycin was 1.62 points.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.79 points higher<br/>(3.02 lower to 4.6 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There might be little or no change in functional impairment due to sleepiness.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of participants with any adverse events<br/>№ of participants: 10<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>OR 0.41<br/>(0.01 to 12.64) </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There might be little difference in adverse events between clarithromycin and placebo.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100.0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83.3%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.7% fewer<br/>(46.5% fewer to 13.2% more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>OR:</b> odds ratio; <b>RCT:</b> randomized controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by two levels for imprecision: confidence interval includes the possibility of harm. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012714-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012714-sec-0009"></div> <section id="CD012714-sec-0010"> <h3 class="title" id="CD012714-sec-0010">Description of the condition</h3> <p>Idiopathic hypersomnia is a chronic neurologic sleep disorder that manifests as excessive daytime sleepiness occurring despite normal or prolonged sleep times (i.e. exceeding 11 hours of sleep per 24‐hour period), in the absence of other disorders that impair sleep quality, such as sleep apnea. Symptoms and signs of idiopathic hypersomnia also include marked sleep inertia (severe and prolonged difficulties with awakening), long and unrefreshing naps, and high measured sleep efficiency in the sleep laboratory, although some people meeting the diagnostic criteria for idiopathic hypersomnia do not experience these classic ancillary symptoms (<a href="./references#CD012714-bbs2-0018" title="AndersonKN , PilsworthS , SharplesLD , SmithIE , ShneersonJM . Idiopathic hypersomnia: a study of 77 cases. Sleep2007;30(10):1274-81.">Anderson 2007</a>; <a href="./references#CD012714-bbs2-0020" title="BassettiC , AldrichMS . Idiopathic hypersomnia: a series of 42 patients. Brain1997;120:1423-35.">Bassetti 1997</a>; <a href="./references#CD012714-bbs2-0028" title="SateiaJ . International Classification of Sleep Disorders, 3rd edition. Darien (IL): American Academy of Sleep Medicine, 2014.">ICSD‐3 2014</a>). Difficulties with concentration and attention are frequently present in people with idiopathic hypersomnia, and quality of life is reduced (<a href="./references#CD012714-bbs2-0039" title="OzakiA , InoueY , HayashidaK , NakajimaT , HondaM , UsuiA , et al. Quality of life in patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time: comparison between patients on psychostimulants, drug-naïve patients and the general Japanese population. Sleep Medicine2012;13(2):200-6.">Ozaki 2012</a>; <a href="./references#CD012714-bbs2-0048" title="VernetC , ArnulfI . Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients. Sleep2009;32(6):753-9.">Vernet 2009</a>; <a href="./references#CD012714-bbs2-0049" title="VernetC , Leu-SemenescuS , BuzareMA , ArnulfI . Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness. Journal of Sleep Research2010;19(4):525-34.">Vernet 2010</a>). </p> <p>The cause of idiopathic hypersomnia remains unknown, although abnormalities of sleep macro‐ and microstructure have been noted (<a href="./references#CD012714-bbs2-0040" title="PizzaF , FerriR , PoliF , VandiS , CosentinoFI , PlazziG . Polysomnographic study of nocturnal sleep in idiopathic hypersomnia without long sleep time. Journal of Sleep Research2013;22(2):185-96.">Pizza 2013</a>; <a href="./references#CD012714-bbs2-0048" title="VernetC , ArnulfI . Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients. Sleep2009;32(6):753-9.">Vernet 2009</a>). Idiopathic hypersomnia, especially that without long nocturnal sleep times, shares many clinical similarities with narcolepsy without cataplexy (narcolepsy type 2), and the two disorders may be indistinguishable except for findings on the Multiple Sleep Latency Test (MSLT) (<a href="./references#CD012714-bbs2-0045" title="ŠonkaK , ŠustaM , BilliardM . Narcolepsy with and without cataplexy, idiopathic hypersomnia with and without long sleep time: a cluster analysis. Sleep Medicine2015;16(2):225-31.">Šonka 2015</a>). At least two major diagnostic classification schema, the International Classification of Sleep Disorders (ICSD) and the Diagnostic and Statistical Manual of Mental Disorders (DSM), have published diagnostic guidelines for this entity, although the diagnostic criteria in the two systems are not identical. The currently preferred terminology is 'idiopathic hypersomnia' in the ICSD, third edition, and 'hypersomnolence disorder' in the DSM‐5. Other previously used terms include idiopathic central nervous system hypersomnolence, non‐rapid eye movement (NREM) narcolepsy, NREM hypersomnia, primary hypersomnia, and hypersomnia with sleep drunkenness. Hypersomnia disorder (DSM‐IV) has a population prevalence of 0.5% in the USA (<a href="./references#CD012714-bbs2-0038" title="OhayonMM , Reynolds CF 3rd, DauvilliersY . Excessive sleep duration and quality of life. Annals of Neurology2013;73(6):785-94.">Ohayon 2013</a>). </p> </section> <section id="CD012714-sec-0011"> <h3 class="title" id="CD012714-sec-0011">Description of the intervention</h3> <p>Multiple medications have been used in clinical practice for the treatment of idiopathic hypersomnia. Many of these medications are known or suspected to be effective in treating excessive daytime sleepiness in other disorders, such as narcolepsy or obstructive sleep apnea, and are then extended for use in idiopathic hypersomnia with or without specific testing in this population. Clinical series suggest that this strategy results in satisfactory symptom control in the majority of people, with a poorer response to treatment in up to one‐third of individuals (<a href="./references#CD012714-bbs2-0017" title="AliM , AugerRR , SlocumbNL , MorgenthalerTI . Idiopathic hypersomnia: clinical features and response to treatment. Journal of Clinical Sleep Medicine2009;5(6):562-8.">Ali 2009</a>; <a href="./references#CD012714-bbs2-0018" title="AndersonKN , PilsworthS , SharplesLD , SmithIE , ShneersonJM . Idiopathic hypersomnia: a study of 77 cases. Sleep2007;30(10):1274-81.">Anderson 2007</a>; <a href="./references#CD012714-bbs2-0020" title="BassettiC , AldrichMS . Idiopathic hypersomnia: a series of 42 patients. Brain1997;120:1423-35.">Bassetti 1997</a>). Medication classes that have been used in the treatment of idiopathic hypersomnia include amphetamines, non‐amphetamine wake‐promoting agents (e.g. modafinil, mazindol), histamine H<sub>3</sub> antagonists/inverse agonists, gamma‐Aminobutyric acid (GABA)‐B/gamma hydroxybutyrate agonists, levothyroxine, alerting antidepressants such as bupropion, melatonin (for sleep inertia), and GABA‐A antagonists (<a href="./references#CD012714-bbs2-0031" title="Leu-SemenescuS , NitturN , GolmardJL , ArnulfI . Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review. Sleep Medicine2014;15(6):681-7.">Leu‐Semenescu 2014</a>; <a href="./references#CD012714-bbs2-0032" title="Leu-SemenescuS , LouisP , ArnulfI . Benefits and risk of sodium oxybate in idiopathic hypersomnia versus narcolepsy type 1: a chart review. Sleep Medicine2016;17:38-44.">Leu‐Semenescu 2016</a>; <a href="./references#CD012714-bbs2-0035" title='MontplaisirJ , FantiniL . Idiopathic hypersomnia: a diagnostic dilemma. A commentary of "Idiopathic hypersomnia" (M. Billiard and Y. Dauvilliers). Sleep Medicine Reviews2001;5:361-2.'>Montplaisir 2001</a>; <a href="./references#CD012714-bbs2-0036" title="MorgenthalerTI , KapurVK , BrownT , SwickTJ , AlessiC , AuroraRN , et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep2007;30(12):1705-11.">Morgenthaler 2007</a>; <a href="./references#CD012714-bbs2-0037" title="NitturN , KonofalE , DauvilliersY , FrancoP , Leu-SemenescuS , CockVC , et al. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review. Sleep Medicine2013;14(1):30-6.">Nittur 2013</a>; <a href="./references#CD012714-bbs2-0042" title="RyeDB , BliwiseDL , ParkerK , TrottiLM , SainiP , FairleyJ , et al. Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors. Science Translational Medicine2012;4(161):161ra151. [DOI: 10.1126/scitranslmed.3004685] [PMID: 23175709]">Rye 2012</a>; <a href="./references#CD012714-bbs2-0044" title="ShinnoH , IshikawaI , YamanakaM , UsuiA , DanjoS , InamiY , et al. Effect of levothyroxine on prolonged nocturnal sleep time and excessive daytime somnolence in patients with idiopathic hypersomnia. Sleep Medicine2011;12(6):578-83.">Shinno 2011</a>; <a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a>; <a href="./references#CD012714-bbs2-0047" title="TrottiLM , SainiP , KoolaC , LaBarberaV , BliwiseDL , RyeDB . Flumazenil for the treatment of refractory hypersomnolence: clinical experience with 153 patients. Journal of Clinical Sleep Medicine2016;12(10):1389-94.">Trotti 2016</a>). </p> </section> <section id="CD012714-sec-0012"> <h3 class="title" id="CD012714-sec-0012">How the intervention might work</h3> <p>Amphetamines both increase the release of and block the reuptake of monoaminergic neurotransmitters (i.e. dopamine, norepinephrine, and serotonin). Their effects on dopaminergic neurotransmission are particularly important for promoting wakefulness (<a href="./references#CD012714-bbs2-0019" title="BanerjeeD , VitielloMV , GrunsteinRR . Pharmacotherapy for excessive daytime sleepiness. Sleep Medicine Review2004;8(5):339–54.">Banerjee 2004</a>; <a href="./references#CD012714-bbs2-0023" title="GowdaCR , LundtLP . Mechanism of action of narcolepsy medications. CNS Spectrums2014;19:25-33.">Gowda 2014</a>). Multiple potential mechanisms of action have been proposed for modafinil, including effects on dopaminergic neurotransmission (<a href="./references#CD012714-bbs2-0019" title="BanerjeeD , VitielloMV , GrunsteinRR . Pharmacotherapy for excessive daytime sleepiness. Sleep Medicine Review2004;8(5):339–54.">Banerjee 2004</a>; <a href="./references#CD012714-bbs2-0023" title="GowdaCR , LundtLP . Mechanism of action of narcolepsy medications. CNS Spectrums2014;19:25-33.">Gowda 2014</a>). The alerting potential of mazindol and bupropion may also be related to their actions as dopamine reuptake inhibitors (<a href="./references#CD012714-bbs2-0025" title="HealDJ , GosdenJ , SmithSL . Dopamine reuptake transporter (DAT) “inverse agonism”—a novel hypothesis to explain the enigmatic pharmacology of cocaine. Neuropharmacology2014;87:19-40.">Heal 2014</a>). Histamine H<sub>3</sub> antagonists/inverse agonists promote wakefulness by increasing central nervous system histamine levels (<a href="./references#CD012714-bbs2-0031" title="Leu-SemenescuS , NitturN , GolmardJL , ArnulfI . Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review. Sleep Medicine2014;15(6):681-7.">Leu‐Semenescu 2014</a>). The mechanism by which agonists of GABA‐B/gamma hydroxybutyrate reduce sleepiness is not known, although deep sleep is increased (<a href="./references#CD012714-bbs2-0023" title="GowdaCR , LundtLP . Mechanism of action of narcolepsy medications. CNS Spectrums2014;19:25-33.">Gowda 2014</a>). Levothyroxine might improve alertness via hormonal effects, or by increasing central nervous system histamine levels (<a href="./references#CD012714-bbs2-0044" title="ShinnoH , IshikawaI , YamanakaM , UsuiA , DanjoS , InamiY , et al. Effect of levothyroxine on prolonged nocturnal sleep time and excessive daytime somnolence in patients with idiopathic hypersomnia. Sleep Medicine2011;12(6):578-83.">Shinno 2011</a>). Because people with idiopathic hypersomnia tend to have a circadian phase delay, evening use of melatonin has been proposed as a method of advancing the circadian rhythm and improving sleep inertia (<a href="./references#CD012714-bbs2-0048" title="VernetC , ArnulfI . Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients. Sleep2009;32(6):753-9.">Vernet 2009</a>). GABA‐A antagonists have been used in people with idiopathic hypersomnia, based on the finding of a positive allosteric modulator of GABA‐A receptors within the cerebrospinal fluid of people who have hypersomnolence (<a href="./references#CD012714-bbs2-0042" title="RyeDB , BliwiseDL , ParkerK , TrottiLM , SainiP , FairleyJ , et al. Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors. Science Translational Medicine2012;4(161):161ra151. [DOI: 10.1126/scitranslmed.3004685] [PMID: 23175709]">Rye 2012</a>), and the known sleep‐promoting effects of the GABA‐A system (<a href="./references#CD012714-bbs2-0033" title="LuJ , GrecoMA . Sleep circuitry and the hypnotic mechanism of GABAA drugs. Journal of Clinical Sleep Medicine2006;2(2):S19-26.">Lu 2006</a>). </p> </section> <section id="CD012714-sec-0013"> <h3 class="title" id="CD012714-sec-0013">Why it is important to do this review</h3> <p>There are currently no medications approved for the treatment of idiopathic hypersomnia by the US Food and Drug Administration, thus all pharmacologic treatment of people with idiopathic hypersomnia in the USA is 'off‐label.' The European Medicines Agency (EMA) has explicitly stated that modafinil should only be used in people with narcolepsy, not in those with idiopathic hypersomnia (<a href="./references#CD012714-bbs2-0022" title="European Medicines Agency. Modafinil. ww.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Modafinil/human_referral_000236.jsp (accessed 3 October 2016).">EMA Modafinil 2010</a>), although modafinil is one of the medications recommended for the treatment of idiopathic hypersomnia in expert consensus guidelines (<a href="./references#CD012714-bbs2-0036" title="MorgenthalerTI , KapurVK , BrownT , SwickTJ , AlessiC , AuroraRN , et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep2007;30(12):1705-11.">Morgenthaler 2007</a>). As a result of this disagreement and lack of regulatory approval, clinical decision‐making regarding treatment of idiopathic hypersomnia can be challenging. Furthermore, medications used for the treatment of idiopathic hypersomnia carry the risk of serious side effects or medication interactions, including, but not limited to, addiction (amphetamines), respiratory depression or coma (sodium oxybate), superinfection and antibiotic resistance (the GABA‐A receptor antagonist clarithromycin), and reduced efficacy of hormonal birth control (modafinil, armodafinil) (<a href="./references#CD012714-bbs2-0029" title="KrahnLE , HershnerS , LoedingLD , MaskiKP , RifkinDI , SelimB , et al. Quality measures for the care of patients with narcolepsy. Journal of Clinical Sleep Medicine2015;11(3):335-55.">Krahn 2015</a>; <a href="./references#CD012714-bbs2-0046" title="TrottiLM , SainiP , FreemanAA , BliwiseDL , GarcíaPS , JenkinsA , et al. Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: clinical experience. Journal of Psychopharmacology2013;28(7):697-702.">Trotti 2013</a>). People with idiopathic hypersomnia and prescribers must carefully weigh the trade‐offs of risk and benefit when choosing a treatment option. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012714-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012714-sec-0014"></div> <p>To assess the effects of medications for daytime sleepiness and related symptoms in individuals with idiopathic hypersomnia and, in particular, whether medications may: </p> <p> <ol id="CD012714-list-0001"> <li> <p>reduce subjective measures of sleepiness;</p> </li> <li> <p>reduce objective measures of sleepiness;</p> </li> <li> <p>reduce symptoms of cognitive dysfunction;</p> </li> <li> <p>improve quality of life; and</p> </li> <li> <p>be associated with adverse events.</p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012714-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012714-sec-0015"></div> <section id="CD012714-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012714-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included parallel or cross‐over randomized controlled trials (RCTs). Double, single, and unblinded trials were eligible for inclusion. In the case of cross‐over studies, we only used the first period. </p> </section> <section id="CD012714-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included studies evaluating treatment effects in people with a diagnosis of idiopathic hypersomnia, of any age and gender. Idiopathic hypersomnia could be diagnosed using the ICSD (any edition) or the equivalent diagnosis within the DSM (any edition; diagnoses of primary hypersomnia or hypersomnolence disorder). Studies involving diagnoses of idiopathic hypersomnia based on clinical assessment, in the absence of diagnostic MSLT findings, were eligible for inclusion if they provided sufficient detail about how the diagnosis was made. </p> <p>Studies that included both people with idiopathic hypersomnia and those with another disorder (e.g. narcolepsy) were eligible for inclusion if data for the subgroup with idiopathic hypersomnia were obtainable. In such cases, we used only the data from the subgroup with idiopathic hypersomnia. </p> </section> <section id="CD012714-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included any medication (at any dose), either prescription or over‐the‐counter, that is hypothesized to help with symptoms of idiopathic hypersomnia or is used to treat sleepiness in other conditions, compared to placebo, another medication, or a behavioral intervention. </p> <p>Studies that allowed the use of other wake‐promoting or psychoactive medications during the trial were eligible for inclusion, if access to such medications was equal in all groups. </p> </section> <section id="CD012714-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD012714-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD012714-list-0002"> <li> <p>Subjective measure of daytime sleepiness using the Epworth Sleepiness Scale (ESS).</p> </li> </ol> </p> </section> <section id="CD012714-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD012714-list-0003"> <li> <p>Other subjective measures of hypersomnia, including other scales quantifying subjective sleepiness, sleep logs or other participant‐completed reports of sleep times, subjective rating scales of sleep drunkenness/sleep inertia. </p> </li> <li> <p>Objective measures of sleepiness, including MSLT mean sleep latency, Maintenance of Wakefulness Test (MWT) mean sleep latency, psychomotor vigilance test (PVT) measures of reaction times, pupillometry, driving simulators or real‐life measured driving performance, actigraphy, 24‐hour ad‐lib polysomnography. </p> </li> <li> <p>Subjective reports of cognitive dysfunction or objective measures of cognitive performance, assessed by standardized questionnaire or testing instruments. </p> </li> <li> <p>Quality of life scales or measures of ability to function in work, school, or other important activities. </p> </li> <li> <p>Adverse events, as measured by:</p> <ol id="CD012714-list-0004"> <li> <p>rate of adverse events;</p> </li> <li> <p>dropout or withdrawal due to adverse events;</p> </li> <li> <p>dropout or withdrawal due to lack of efficacy.</p> </li> </ol> </li> </ol> </p> </section> </section> </section> <section id="CD012714-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012714-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases on 4 February 2021:</p> <p> <ol id="CD012714-list-0005"> <li> <p>Cochrane Register of Studies (CRS Web), using the search strategy shown in <a href="./appendices#CD012714-sec-0080">Appendix 1</a>; </p> </li> <li> <p>MEDLINE (Ovid) 1946 to 1 February 2021, using the search strategy shown in <a href="./appendices#CD012714-sec-0081">Appendix 2</a>. </p> </li> </ol> </p> <p>CRS Web includes randomized or quasi‐randomized controlled trials from PubMed, Embase, the US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP), the Cochrane Central Register of Controlled Trials (CENTRAL), and the specialized registers of Cochrane Review Groups, including the Cochrane Epilepsy Group. We previously searched WHO ICTRP (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>) separately, using the search strategy shown in <a href="./appendices#CD012714-sec-0082">Appendix 3</a>, when loading of WHO ICTRP records into CRS Web was temporarily suspended. </p> </section> <section id="CD012714-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We reviewed relevant conference proceedings (e.g. the abstract book from the Associated Professional Sleep Societies' annual SLEEP meeting) and systematic reviews, as well as the reference lists of included studies, for additional relevant studies. </p> </section> </section> <section id="CD012714-sec-0026"> <h3 class="title" id="CD012714-sec-0026">Data collection and analysis</h3> <section id="CD012714-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently screened all titles and abstracts of publications identified by the search. We excluded any publications that clearly did not meet the inclusion criteria, as judged independently by both review authors, and obtained the full texts of the remaining publications to identify studies for inclusion in the review. In the case where one of the review authors was an investigator on an identified study, that review author did not take part in decision‐making about that study. Instead, two review authors not involved in the study decided on its eligibility. Any disagreements over study inclusion were resolved by consensus. </p> </section> <section id="CD012714-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>We used a data extraction form within <a href="./references#CD012714-bbs2-0021" title="www.covidence.org.">Covidence</a>. Two review authors independently extracted characteristics of each included trial from the published reports, resolving any disagreements by consensus. Review authors who were investigators on an included study did not participate in extraction of data for that study. Where a published report did not contain sufficient information, we contacted the study investigators to request additional data, including cases where review authors were also investigators on an included study. </p> <p>We extracted the following data items.</p> <section id="CD012714-sec-0029"> <h5 class="title">Participant factors</h5> <p> <ol id="CD012714-list-0006"> <li> <p>Age.</p> </li> <li> <p>Sex.</p> </li> <li> <p>Baseline MSLT results.</p> </li> <li> <p>Baseline sleep length (by actigraphy, sleep log, 24‐hour polysomnography, or other measure). </p> </li> <li> <p>Baseline subjective sleepiness severity.</p> </li> </ol> </p> </section> <section id="CD012714-sec-0030"> <h5 class="title">Trial design</h5> <p> <ol id="CD012714-list-0007"> <li> <p>Study design (randomization, blinding, parallel versus cross‐over).</p> </li> <li> <p>Study duration, start date, and end date.</p> </li> <li> <p>Country of first author.</p> </li> <li> <p>Where the study was conducted (both country and care setting, e.g. tertiary referral center for idiopathic hypersomnia versus general sleep clinic). </p> </li> <li> <p>Multi‐ or single‐center trial.</p> </li> <li> <p>Study inclusion and exclusion criteria.</p> </li> <li> <p>Criteria used to define idiopathic hypersomnia.</p> </li> <li> <p>People with idiopathic hypersomnia only, or people from multiple diagnostic categories included. </p> </li> <li> <p>Number of participants enrolled and number completing in each intervention group.</p> </li> <li> <p>Number and type of wake‐promoting or psychoactive medications allowed as co‐interventions during the trial. </p> </li> <li> <p>Funding source.</p> </li> </ol> </p> </section> <section id="CD012714-sec-0031"> <h5 class="title">Intervention and control</h5> <p> <ol id="CD012714-list-0008"> <li> <p>Active and control interventions (e.g. type, dosing, duration, etc.).</p> </li> <li> <p>Outcomes measured.</p> </li> <li> <p>Adverse events.</p> </li> <li> <p>Any subgroup analyses performed.</p> </li> </ol> </p> </section> </section> <section id="CD012714-sec-0032"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors assessed risk of bias of the included studies using the Cochrane 'Risk of bias' tool, according to the guidelines in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012714-bbs2-0026" title="Higgins JPT , Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Available from www.handbook.cochrane.org edition. The Cochrane Collaboration, 2011.">Higgins 2011</a>). Where a review author was an investigator on an included study, two review authors not involved in the trial undertook the 'Risk of bias' assessment. </p> <p>Risk of bias was assessed as low risk, high risk, or unclear risk, for each of the following characteristics. </p> <p> <ol id="CD012714-list-0009"> <li> <p>Sequence generation</p> </li> <li> <p>Allocation concealment</p> </li> <li> <p>Blinding of participants and personnel</p> </li> <li> <p>Blinding of outcome assessors</p> </li> <li> <p>Incomplete outcome data</p> </li> <li> <p>Selective outcome reporting</p> </li> <li> <p>Other potential threats to validity</p> </li> </ol> </p> </section> <section id="CD012714-sec-0033"> <h4 class="title">Measures of treatment effect</h4> <p>We performed statistical analyses in accordance with the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012714-bbs2-0027" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>). For continuous data available as means and standard deviations, we calculated the mean difference (MD) with 95% confidence interval (CI) to measure treatment effect.  For dichotomous data and adverse event data, we used odds ratio (OR) with 95% CI. </p> </section> <section id="CD012714-sec-0034"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the individual trial participant. In the case of cross‐over trials, we only considered data from the first treatment period. </p> </section> <section id="CD012714-sec-0035"> <h4 class="title">Dealing with missing data</h4> <p>Studies that included any outcome of interest were eligible for inclusion, even if they did not measure the ESS, the primary outcome of this review. However, all included studies used the ESS. We intended to use intention‐to‐treat analyses whenever possible to deal with missing data, but the included studies did not have substantial missing data. </p> </section> <section id="CD012714-sec-0036"> <h4 class="title">Assessment of heterogeneity</h4> <p>For each intervention effect with sufficient data, we tested heterogeneity using the standard Chi<sup>2</sup> and I<sup>2</sup> statistics, considering a P value of less than 0.10 as suggestive of heterogeneity. We had planned to assess possible sources of heterogeneity via subgroup analyses, if sufficient numbers of trials were available. However, our largest meta‐analysis included only two studies, limiting our ability to assess for sources of heterogeneity. </p> </section> <section id="CD012714-sec-0037"> <h4 class="title">Assessment of reporting biases</h4> <p>We compared published protocols to study reports to assess incomplete outcome reporting.</p> </section> <section id="CD012714-sec-0038"> <h4 class="title">Data synthesis</h4> <p>We generated effect estimates using random‐effects meta‐analyses included in RevMan Web  (<a href="./references#CD012714-bbs2-0041" title="The Cochrane CollaborationReview Manager Web (RevMan Web). Version 2.5.1. The Cochrane Collaboration, 2021. Available at revman.cochrane.org.">Review Manager 2020</a>). </p> </section> <section id="CD012714-sec-0039"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We prespecified subgroup analyses for those with long sleep versus normal sleep duration, and by method of diagnosis of idiopathic hypersomnia (e.g. comparing those meeting MSLT criteria versus those with a clinical diagnosis lacking MSLT criteria; ICSD versus DSM criteria; MSLT versus measured total sleep time of &gt; 660 minutes). However, there were insufficient data to perform these analyses. </p> </section> <section id="CD012714-sec-0040"> <h4 class="title">Sensitivity analysis</h4> <p>We prespecified sensitivity analyses, as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012714-bbs2-0027" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>), to evaluate the effect of including versus excluding those studies at high risk of bias. We did not identify any studies at high risk of bias. </p> </section> <section id="CD012714-sec-0041"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We used the GRADE approach to interpret findings (<a href="./references#CD012714-bbs2-0043" title="SchünemannHJ , VistGE , HigginsJPT , SantessoN , DeeksJJ , GlasziouP , et al. Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Schünemann 2021</a>). We used <a href="./references#CD012714-bbs2-0024" title="McMaster University (developed by Evidence Prime)GRADEPro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), multiple access dates; most recent 3/8/21. Available at gradepro.org.">GRADEpro GDT</a> software to create 'Summary of findings' tables for each comparison included in the review for the primary outcome and the adverse events outcome (<a href="./references#CD012714-bbs2-0024" title="McMaster University (developed by Evidence Prime)GRADEPro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), multiple access dates; most recent 3/8/21. Available at gradepro.org.">GRADEpro GDT</a>).<br/>The 'Summary of findings' table for each comparison includes information on overall certainty of the evidence from the trials and information of importance for healthcare decision‐making. The GRADE approach determines the certainty of evidence on the basis of an evaluation of eight criteria (risk of bias, inconsistency, indirectness, imprecision, publication bias, effect size, presence of plausible confounding that will change effect, and dose‐response gradient). We used the GRADE criteria for evaluating RCTs to guide our conclusions. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012714-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012714-sec-0042"></div> <section id="CD012714-sec-0043"> <h3 class="title">Description of studies</h3> <section id="CD012714-sec-0044"> <h4 class="title">Results of the search</h4> <p>We identified 510 references from the literature search and other sources, 78 of which were duplicates (see <a href="#CD012714-fig-0001">Figure 1</a>). We judged 409 of these references to be irrelevant based on title and abstract screening. We assessed the remaining 23 studies for eligibility via review of full text, published abstract, clinical trial registration, or a combination of these, depending on availability. Five of these studies were ongoing (<a href="./references#CD012714-bbs2-0012" title="NCT03542851. A randomized, placebo-controlled, double-blind, crossover study of oral BTD-001 in adults with idiopathic hypersomnia. clinicaltrials.gov/show/NCT03542851 (first received 31 May 2018). ">NCT03542851</a>; <a href="./references#CD012714-bbs2-0013" title="NCT03597555. Sodium oxybate for idiopathic hypersomnia. clinicaltrials.gov/show/NCT03597555 (first received 24 July 2018). ">NCT03597555</a>; <a href="./references#CD012714-bbs2-0014" title="NCT03772314. Modafinil versus amphetamines for the treatment of narcolepsy type 2 and idiopathic hypersomnia. clinicaltrials.gov/ct2/show/NCT03772314 (first received 11 December 2018). ">NCT03772314</a>; <a href="./references#CD012714-bbs2-0015" title="NCT04026958. Clarithromycin mechanisms in hypersomnia syndromes. clinicaltrials.gov/ct2/show/NCT04026958. ">NCT04026958</a>; <a href="./references#CD012714-bbs2-0016" title="NCT04091438. A phase 1b randomized, double-blind, placebo-controlled, crossover study of a single intravenous infusion dose of TAK-925 in patients With idiopathic hypersomnia. clinicaltrials.gov/ct2/show/NCT04091438. ">NCT04091438</a>), and three were recently completed but unpublished, and therefore awaiting classification (<a href="./references#CD012714-bbs2-0009" title="EUCTR2017-002127-16. A phase IIa study of GR3027 in patients with idiopathic hypersomnia (IH) involving an open-label part to assess safety, tolerability and pharmacokinetics (PK) of a single oral GR3027 dose in female patients and a randomized, double-blind, placebo-controlled crossover study to assess safety, tolerability, exposure and exploratory efficacy of multiple oral doses of GR3027 in male and female IH patients. www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002127-16 (first received 5 July 2017). ">EUCTR2017‐002127‐16</a>; <a href="./references#CD012714-bbs2-0010" title="NCT02512588. A study of safety and efficacy of BTD-001 in treatment of patients with idiopathic hypersomnia (IH) or narcolepsy type 2. clinicaltrials.gov/show/NCT02512588 (first received 31 July 2015). ">NCT02512588</a>; <a href="./references#CD012714-bbs2-0011" title="NCT03533114. A multicenter study of the efficacy and safety of JZP-258 in the treatment of idiopathic hypersomnia (IH) with an open-label safety extension. clinicaltrials.gov/show/NCT03533114 (first received 22 May 2018). ">NCT03533114</a>). We excluded seven publications that were additional publications referring to a study already assessed as irrelevant, ongoing, or excluded. We excluded five additional studies for methodological reasons (see <a href="#CD012714-sec-0046">Excluded studies</a>). We included three studies in the review. </p> <div class="figure" id="CD012714-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012714-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012714-sec-0045"> <h4 class="title">Included studies</h4> <p>Two of the three included studies compared modafinil versus placebo, and one study compared clarithromycin versus placebo. </p> <p><a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a> was a placebo‐controlled, double‐blind, randomized, parallel‐group study of modafinil, 100 mg in the morning and 100 mg at noon for three weeks. The trial enrolled 33 participants, and included 31 participants in the analyses who had received either modafinil or placebo. The trial recruited participants from three sleep centers in Germany. Participants were diagnosed with idiopathic hypersomnia without long sleep time, based on the ICSD‐2. Outcomes included ESS, MWT, Clinical Global Impression of Severity (CGI‐S), participant‐reported weekly nap frequency, participant‐reported daytime sleep per week, and participant‐reported effectiveness/performance (rated on a 1‐to‐6‐point scale every evening, where lower numbers indicated better performance). When the study presented data as means and standard deviations, we used the published values for week 3 measures. For outcomes not reported in the publication, we used data provided by Professor Mayer to calculate the mean and standard deviation. This study was funded by Cephalon. </p> <p><a href="./references#CD012714-bbs2-0001" title="InoueY , TabataT , TsukimoriN . Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine (in press). [DOI: 10.1016/j.sleep.2021.01.018]">Inoue 2021</a> was a placebo‐controlled, double‐blind, randomized, parallel‐group study of modafinil, 200 mg in the morning for three weeks. The study included 71 participants across multiple sites in Japan, 70 of whom completed the study. Participants were diagnosed with idiopathic hypersomnia based on the ICSD‐2. The majority (69/71) had idiopathic hypersomnia without long sleep time; two participants had idiopathic hypersomnia with long sleep time. The outcomes included ESS (using the Japanese translation), MWT, CGI of Change (CGI‐C), participant‐reported weekly nap frequency, and nocturnal polysomnography. This study was funded by Alfresa Pharmaceuticals. </p> <p><a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a> was a placebo‐controlled, double‐blind, randomized, cross‐over trial of clarithromycin, 500 mg in the morning and 500 mg at noon for two weeks. The trial randomly assigned 23 people from a single sleep center in the USA, and included 20 participants in the analyses, of which 10 had idiopathic hypersomnia (diagnosed by the ICSD‐2, five with long sleep time and five without long sleep time). In accordance with our protocol, we only included data from these 10 participants in the review. Outcomes included ESS, a 10‐point single‐item assessment of sleep inertia, sleep log, PVT, Functional Outcomes of Sleep Questionnaire (FOSQ), the 36‐item Short Form Health Survey (SF‐36), Stanford Sleepiness Scale (SSS), and Pittsburgh Sleep Quality Index (PSQI). This study was funded by the American Academy of Sleep Medicine Foundation. </p> </section> <section id="CD012714-sec-0046"> <h4 class="title">Excluded studies</h4> <p>Two RCTs of modafinil for excessive daytime sleepiness included participants with idiopathic hypersomnia and evaluated several of our outcomes of interest (<a href="./references#CD012714-bbs2-0007" title="PhilipP , ChauftonC , TaillardJ , CapelliA , CosteO , LegerD , et al. Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial. Sleep2014;37(3):483-7. [DOI: 10.5665/sleep.3480] [PMID: 24587570]">Philip 2014</a>; <a href="./references#CD012714-bbs2-0008" title="SagaspeP , Micoulaud-FranchiJA , CosteO , LegerD , EspieS , DavenneD , et al. Maintenance of wakefulness test, real and simulated driving in patients with narcolepsy/hypersomnia. Sleep Medicine2019;55:1-5. ">Sagaspe 2019</a>). However, these trials only provided data in aggregate for participants with idiopathic hypersomnia and those with narcolepsy, and were therefore excluded based on our inclusion criteria. </p> <p>One randomized controlled trial of flumazenil for excessive daytime sleepiness included participants with idiopathic hypersomnia and evaluated outcomes of interest to this review (<a href="./references#CD012714-bbs2-0005" title="NCT01183312. Flumazenil for the treatment of primary hypersomnia. clinicaltrials.gov/show/NCT01183312 (first received 17 August 2010). ">NCT01183312</a>). However, only a single participant had idiopathic hypersomnia, therefore we excluded this study. </p> <p>We excluded one study that did not use the current terminology for hypersomnia syndromes, included a mixture of different diagnoses, and was not a controlled trial (<a href="./references#CD012714-bbs2-0006" title="NodineJH , BodiT , SlapJ , LevyHA , SieglerPE . Preliminary trial of a new stimulant SCH 5472 in ambulatory patients with depression, exhaustion, or hypersomnia syndrome. Antibiotic Medicine &amp; Clinical Therapy1960;7:771-6. [PMID: 13729397]">Nodine 1960</a>). </p> <p>The excluded <a href="./references#CD012714-bbs2-0004" title="JapicCTI-142615. Long-term study of CN-801 in patients with idiopathic hypersomnia. www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-142615 (first received 23 July 2014). ">JapicCTI‐142615</a> study was an open‐label extension of an included controlled trial (<a href="./references#CD012714-bbs2-0001" title="InoueY , TabataT , TsukimoriN . Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine (in press). [DOI: 10.1016/j.sleep.2021.01.018]">Inoue 2021</a>). </p> </section> </section> <section id="CD012714-sec-0047"> <h3 class="title">Risk of bias in included studies</h3> <p>We judged the included studies to be at low risk of bias (<a href="#CD012714-fig-0002">Figure 2</a>; <a href="#CD012714-fig-0003">Figure 3</a>) </p> <div class="figure" id="CD012714-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012714-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD012714-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012714-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012714-sec-0048"> <h4 class="title">Allocation</h4> <p>All studies had a low risk of selection bias, considering both random sequence generation and allocation concealment (<a href="./references#CD012714-bbs2-0001" title="InoueY , TabataT , TsukimoriN . Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine (in press). [DOI: 10.1016/j.sleep.2021.01.018]">Inoue 2021</a>; <a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a>; <a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a>). </p> </section> <section id="CD012714-sec-0049"> <h4 class="title">Blinding</h4> <p>All three studies were reported as double‐blind trials, and where therefore judged to be at low risk for performance and detection bias (<a href="./references#CD012714-bbs2-0001" title="InoueY , TabataT , TsukimoriN . Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine (in press). [DOI: 10.1016/j.sleep.2021.01.018]">Inoue 2021</a>; <a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a>; <a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a>). All of the included studies provided additional data about blinding by the pharmacy or third‐party. </p> </section> <section id="CD012714-sec-0050"> <h4 class="title">Incomplete outcome data</h4> <p>All three trials analyzed data for the majority of enrolled participants with idiopathic hypersomnia, and were therefore judged to be low risk of attrition bias (<a href="./references#CD012714-bbs2-0001" title="InoueY , TabataT , TsukimoriN . Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine (in press). [DOI: 10.1016/j.sleep.2021.01.018]">Inoue 2021</a>; <a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a>; <a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a>). The <a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a> study analyzed 31 of 33 participants; one participant was a screen‐fail, and a second dropped out at baseline. The <a href="./references#CD012714-bbs2-0001" title="InoueY , TabataT , TsukimoriN . Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine (in press). [DOI: 10.1016/j.sleep.2021.01.018]">Inoue 2021</a> study analyzed data for adverse events in 71 of 71 enrolled participants, and other outcomes in the 70 participants who completed the study. Regarding the <a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a> study, we only included data from the 10 participants with idiopathic hypersomnia in this review, and all 10 enrolled participants with idiopathic hypersomnia completed the study. </p> </section> <section id="CD012714-sec-0051"> <h4 class="title">Selective reporting</h4> <p>We judged the risk of reporting bias to be low across all three included studies (<a href="./references#CD012714-bbs2-0001" title="InoueY , TabataT , TsukimoriN . Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine (in press). [DOI: 10.1016/j.sleep.2021.01.018]">Inoue 2021</a>; <a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a>; <a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a>). All three studies were registered at clinical trials registries, and all three reported data on their primary outcomes and other outcomes listed in registration documents. All three studies reported results for the ESS, which is a very commonly used self‐report measure of sleepiness severity and the primary outcome measure of this review. All studies also reported an objective measure of sleepiness or vigilance, two with the MWT and one with the PVT. </p> </section> <section id="CD012714-sec-0052"> <h4 class="title">Other potential sources of bias</h4> <p>We judged all of the included studies to be at low risk for other sources of bias.</p> </section> </section> <section id="CD012714-sec-0053"> <h3 class="title" id="CD012714-sec-0053">Effects of interventions</h3> <p>See: <a href="./full#CD012714-tbl-0001"><b>Summary of findings 1</b> Modafinil compared to placebo for idiopathic hypersomnia</a>; <a href="./full#CD012714-tbl-0002"><b>Summary of findings 2</b> Clarithromycin compared to placebo for idiopathic hypersomnia</a> </p> <section id="CD012714-sec-0054"> <h4 class="title">Modafinil versus placebo</h4> <section id="CD012714-sec-0055"> <h5 class="title">Subjective sleepiness as measured by the Epworth Sleepiness Scale (ESS)</h5> <p>Two studies evaluated the effect of modafinil versus placebo on our primary outcome, subjective sleepiness measured by the ESS (<a href="./references#CD012714-bbs2-0001" title="InoueY , TabataT , TsukimoriN . Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine (in press). [DOI: 10.1016/j.sleep.2021.01.018]">Inoue 2021</a>; <a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a>). Participants taking modafinil had significantly lower ESS scores at week 3 than did those on placebo, by 5.08 points (95% confidence interval (CI) 7.16 to 3.01 points lower with modafinil, I<sup>2</sup> = 15%, 2 studies, 101 participants; <a href="./references#CD012714-fig-0006" title="">Analysis 1.1</a>; <a href="#CD012714-fig-0004">Figure 4</a>; <a href="./full#CD012714-tbl-0001">summary of findings Table 1</a>).  </p> <div class="figure" id="CD012714-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Modafinil versus placebo, Analysis 1.1: Subjective sleepiness, using Epworth Sleepiness Scale, week 3" data-id="CD012714-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Modafinil versus placebo, <a href="./references#CD012714-fig-0006" title="">Analysis 1.1</a>: Subjective sleepiness, using Epworth Sleepiness Scale, week 3 </p> </div> </div> </div> </section> <section id="CD012714-sec-0056"> <h5 class="title">Other subjective measures of sleepiness or hypersomnia</h5> <p>We considered other subjective measures of hypersomnia as secondary outcomes for this review. Two studies included reported weekly nap frequency (<a href="./references#CD012714-bbs2-0001" title="InoueY , TabataT , TsukimoriN . Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine (in press). [DOI: 10.1016/j.sleep.2021.01.018]">Inoue 2021</a>; <a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a>), and one study reported total minutes of daytime sleep per week (<a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a>). There was no difference in weekly nap frequency at week 3 between the modafinil and placebo groups (mean difference (MD) 2.01 fewer naps/week in the modafinil group, 95% CI 5.50 fewer to 1.48 more naps, I<sup>2</sup> = 81%, 2 studies, 99 participants; <a href="./references#CD012714-fig-0007" title="">Analysis 1.2</a> (1.2.1)). There was no difference in total minutes of daytime sleep at week 3 between modafinil and placebo groups in the <a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a> study (MD 7.00 minutes more in the modafinil group, 95% CI 81.59 less to 95.59 minutes more; <a href="./references#CD012714-fig-0007" title="">Analysis 1.2</a> (1.2.2)). </p> <p>The <a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a> study reported several sleep diary measures that were assessed daily and then averaged across a one‐week period. These measures included: exhaustion (4‐point scale, lower numbers signify less exhaustion), feeling of being refreshed (measurement unspecified), and nocturnal sleep duration. Use of modafinil reduced ratings of exhaustion at week 3 to a greater extent than did placebo (MD 0.67 points lower with modafinil than placebo, 95% CI 1.13 points lower to 0.21 points lower; <a href="./references#CD012714-fig-0007" title="">Analysis 1.2</a> (1.2.3)). Change from baseline to week 3 in nocturnal sleep time from sleep logs did not differ between treatments (MD 0.25 hours less in the modafinil group, 95% CI 0.98 less to 0.48 hours more sleep in modafinil group; <a href="./references#CD012714-fig-0007" title="">Analysis 1.2</a> (1.2.4)). The study did not provide data for feelings of being refreshed, although the study authors noted that the modafinil group became more refreshed with treatment compared to baseline, whereas the placebo group had no change on this measure. </p> <p>Two studies assessed CGI, using different measures. The <a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a> study evaluated change from baseline in Clinical Global Impression of Severity (CGI‐S). Modafinil resulted in a greater improvement from baseline to week 3 on the CGI‐S than did placebo, by 1.02 points (95% CI improved by 1.93 to 0.11 points; <a href="./references#CD012714-fig-0008" title="">Analysis 1.3</a>). The <a href="./references#CD012714-bbs2-0001" title="InoueY , TabataT , TsukimoriN . Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine (in press). [DOI: 10.1016/j.sleep.2021.01.018]">Inoue 2021</a> study evaluated the percentage of participants who were "much improved" or "very much improved" on the CGI of Change. Modafinil resulted in a significantly greater proportion of participants who were much or very much improved (odds ratio (OR) 5.14, 95% CI 1.76 to 15.00; <a href="./references#CD012714-fig-0009" title="">Analysis 1.4</a>). </p> <p>Neither study included measures of sleep drunkenness/sleep inertia.</p> </section> <section id="CD012714-sec-0057"> <h5 class="title">Objective measures of hypersomnia</h5> <p>Both modafinil studies used Maintenance of Wakefulness Test (MWT) mean sleep latency as the objective measure of sleepiness (<a href="./references#CD012714-bbs2-0001" title="InoueY , TabataT , TsukimoriN . Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine (in press). [DOI: 10.1016/j.sleep.2021.01.018]">Inoue 2021</a>; <a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a>). Modafinil resulted in a significantly longer mean sleep latency at week 3 than did placebo, by 4.74 minutes (95% CI 2.46 to 7.01 minutes longer; I<sup>2 </sup>= 0%; 2 studies, 99 participants; <a href="./references#CD012714-fig-0010" title="">Analysis 1.5</a>; <a href="#CD012714-fig-0005">Figure 5</a>).    </p> <div class="figure" id="CD012714-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Modafinil versus placebo, Analysis 1.5: Objective sleepiness, using Maintenance of Wakefulness Test, week 3." data-id="CD012714-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Modafinil versus placebo, <a href="./references#CD012714-fig-0010" title="">Analysis 1.5</a>: Objective sleepiness, using Maintenance of Wakefulness Test, week 3. </p> </div> </div> </div> <p>The <a href="./references#CD012714-bbs2-0001" title="InoueY , TabataT , TsukimoriN . Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine (in press). [DOI: 10.1016/j.sleep.2021.01.018]">Inoue 2021</a> study also included nocturnal polysomnographic measures, including sleep latency, total sleep time, and percentage of sleep stages. These results were not detailed, but it was noted that changes in these parameters from baseline to week 3 did not differ between the modafinil and placebo groups.   </p> </section> <section id="CD012714-sec-0058"> <h5 class="title">Cognitive performance</h5> <p>Neither study of modafinil used subjective reports of cognitive dysfunction or objective measures of cognitive performance. </p> </section> <section id="CD012714-sec-0059"> <h5 class="title">Quality of life or ability to function</h5> <p>The <a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a> study used a subjective report of ability to function via a single, 6‐point measure of "effectiveness/performance" reported every evening and then averaged across each week. At week 3, this measure was better in the modafinil group than in the placebo group, by 0.68 points (95% CI 1.26 to 0.1 points better in the modafinil group; <a href="./references#CD012714-fig-0011" title="">Analysis 1.6</a>). </p> </section> <section id="CD012714-sec-0060"> <h5 class="title">Adverse events</h5> <p>Both studies reported adverse events (<a href="./references#CD012714-bbs2-0001" title="InoueY , TabataT , TsukimoriN . Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine (in press). [DOI: 10.1016/j.sleep.2021.01.018]">Inoue 2021</a>; <a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a>). Participants receiving modafinil  experienced more side effects than those in the placebo group, although the difference did not reach statistical significance (OR 1.68, 95% CI 0.28 to 9.94; I<sup>2 </sup>= 76%; 2 studies, 102 participants; <a href="./references#CD012714-fig-0012" title="">Analysis 1.7</a>). In the <a href="./references#CD012714-bbs2-0001" title="InoueY , TabataT , TsukimoriN . Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine (in press). [DOI: 10.1016/j.sleep.2021.01.018]">Inoue 2021</a> study, there was no significant difference between groups in dropout due to adverse events (OR 3.36, 95% CI 0.13 to 85.26). In the <a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a> study, there were no dropouts due to adverse events in either group. There were no dropouts due to lack of efficacy in either study. </p> <p>In the <a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a> study, individual adverse events of headache and gastrointestinal symptoms were more common in the modafinil group. Headache occurred in 26.4% of the modafinil group and 3.3% of the placebo group, whereas gastrointestinal symptoms occurred in 19.8% and 6.6% of participants in the modafinil and placebo groups, respectively. In the <a href="./references#CD012714-bbs2-0001" title="InoueY , TabataT , TsukimoriN . Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine (in press). [DOI: 10.1016/j.sleep.2021.01.018]">Inoue 2021</a> study, headache occurred in 17.6% of the modafinil group and 8.1% of the placebo group. Gastrointestinal symptoms were listed individually in this study, with nausea occurring in 8.8% of participants in the modafinil group and none in the placebo group; diarrhea in 5.9% of participants in the modafinil group and none in the placebo group; and loss of appetite in 5.9% of participants in the modafinil group and none in the placebo group.   </p> </section> </section> <section id="CD012714-sec-0061"> <h4 class="title">Clarithromycin versus placebo</h4> <section id="CD012714-sec-0062"> <h5 class="title">Subjective sleepiness as measured by the Epworth Sleepiness Scale (ESS)</h5> <p>One study evaluated the effect of clarithromycin versus placebo on our primary outcome, subjective sleepiness measured by the ESS (<a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a>). As stated in our protocol (<a href="./references#CD012714-bbs2-0050" title="TrottiLM , BeckerLA , Friederich MurrayC , HoqueR . Medications for daytime sleepiness in individuals with idiopathic hypersomnia. Cochrane Database of Systematic Reviews2017, Issue 7. Art. No: CD012714. [DOI: 10.1002/14651858.CD012714]">Trotti 2017</a>), we only used data for those participants with idiopathic hypersomnia, and only from the first period of this cross‐over study. The change in ESS score from baseline to on‐treatment (an average of week 1 and week 2 scores) did not differ between participants with idiopathic hypersomnia initially randomized to clarithromycin and those randomized to placebo (MD 0.50 points more improvement in the clarithromycin group, 95% CI 5.04 points more to 4.04 points less to improvement in the clarithromycin group; <a href="./references#CD012714-fig-0013" title="">Analysis 2.1</a>; <a href="./full#CD012714-tbl-0002">summary of findings Table 2</a>). </p> </section> <section id="CD012714-sec-0063"> <h5 class="title">Other subjective measures of sleepiness or hypersomnia</h5> <p>The <a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a> study also included other subjective measures of hypersomnia, including the SSS, sleep log, and a 10‐point scale assessing difficulty in awakening every morning. Change from baseline to on‐treatment (average of weeks 1 and 2) for the SSS did not differ between clarithromycin and placebo groups (MD 0.33 points more improvement in the clarithromycin group, 95% CI 2.00 points better in the clarithromycin group to 1.34 better in the placebo group; <a href="./references#CD012714-fig-0014" title="">Analysis 2.2</a> (2.2.1)). Sleep time was calculated from sleep diaries and averaged across each two‐week treatment period. Sleep duration did not differ between the clarithromycin and placebo groups (MD 79.67 minutes less sleep in the clarithromycin group, 95% CI 171.71 minutes less to 12.37 minutes more in the clarithromycin group; <a href="./references#CD012714-fig-0014" title="">Analysis 2.2</a> (2.2.2)). Difficulty waking in the morning (a measure of sleep inertia) did not differ between groups (MD 0.31 points harder in the clarithromycin group, 95% CI 2.00 points easier to 2.62 points harder in the clarithromycin group; <a href="./references#CD012714-fig-0014" title="">Analysis 2.2</a> (2.2.3)). </p> </section> <section id="CD012714-sec-0064"> <h5 class="title">Objective measures of hypersomnia</h5> <p>The <a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a> study evaluated performance on the psychomotor vigilance test (PVT) as an objective measure of sleepiness using the reciprocal of reaction time, a measure of the speed of participants' reaction to stimuli. For this measure, the change from baseline did not differ between clarithromycin and placebo groups (MD improved by 0.51 more in the placebo group, 95% CI improved by 1.19 more to 0.17 less in the placebo group; <a href="./references#CD012714-fig-0015" title="">Analysis 2.3</a>). </p> </section> <section id="CD012714-sec-0065"> <h5 class="title">Cognitive performance</h5> <p><a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a> did not include any measures of cognitive function. </p> </section> <section id="CD012714-sec-0066"> <h5 class="title">Quality of life or ability to function</h5> <p>The <a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a> study included two measures of quality of life or functional impairment. The trialists measured quality of life using the SF‐36 subscales. There were no differences between clarithromycin and placebo groups on any of the SF‐36 subscales (data not shown). Functional impairment due to sleepiness was assessed using the FOSQ, but this did not differ between clarithromycin and placebo groups (MD 0.79 points more improved in the clarithromycin group, 95% CI 3.02 less improved to 4.60 points more improved in the clarithromycin group; <a href="./references#CD012714-fig-0016" title="">Analysis 2.4</a>). </p> </section> <section id="CD012714-sec-0067"> <h5 class="title">Adverse events</h5> <p>The overall rate of any adverse event did not differ between clarithromycin and placebo groups in the <a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a> study (OR 0.41 for any adverse event in the clarithromycin group, 95% CI 0.01 to 12.64; <a href="./references#CD012714-fig-0017" title="">Analysis 2.5</a>). There were no dropouts in either group due to adverse events or lack of efficacy. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012714-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012714-sec-0068"></div> <section id="CD012714-sec-0069"> <h3 class="title" id="CD012714-sec-0069">Summary of main results</h3> <p>Modafinil is effective for the treatment of several aspects of idiopathic hypersomnia symptoms. Two RCTs showed reductions in Epworth Sleepiness Scale (ESS) scores, our primary measure of daytime sleepiness. Objective sleepiness, as measured by the Maintenance of Wakefulness Test (MWT) sleep latency, also significantly improved with modafinil in these two studies. Clinical Global Impression (CGI) improved in both studies, measured as change in severity in one study, and proportion of participants who were much or very much improved in the other study. Exhaustion and effectiveness/performance both improved in a single study. Weekly nap frequency did not significantly improve in the two studies. The increase in adverse events in the modafinil group did not reach statistical significance. Dropout due to adverse event was not significantly different between modafinil and placebo groups. </p> <p>The available data were insufficient to determine whether clarithromycin is superior to placebo for the treatment of idiopathic hypersomnia. Further studies of this intervention would better clarify its effects. </p> </section> <section id="CD012714-sec-0070"> <h3 class="title" id="CD012714-sec-0070">Overall completeness and applicability of evidence</h3> <p>The currently available evidence in support of the optimal treatment for people with idiopathic hypersomnia is limited. The intervention studied the most in RCTs is modafinil, for which the total sample size in the included studies was 102 participants. One of these trials had a target sample size of 40 participants based on power calculations (<a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a>), but only 31 participants completed the study, which may have reduced the ability of the study to find beneficial or harmful effects of modafinil. Two excluded modafinil RCTs included participants with idiopathic hypersomnia, but disease‐specific data were not available from these trials. Nearly all participants in the included studies had idiopathic hypersomnia without long sleep time (per International Classification of Sleep Disorders (ICSD‐2) diagnostic criteria), therefore it is currently unknown whether modafinil would be similarly effective in people with ICSD‐2‐defined idiopathic hypersomnia with long sleep time. Idiopathic hypersomnia is no longer subdivided into with and without long sleep time in the ICSD‐3.  </p> <p>Clarithromycin is the only other intervention for which RCT data have been published as of the writing of this review, despite the use of a broader range of medications in clinical practice. Several recently completed or ongoing studies will add to the evidence base for idiopathic hypersomnia once data become available.   </p> <section id="CD012714-sec-0071"> <h4 class="title">Certainty of the evidence</h4> <p>The certainty of the evidence for the outcomes of interest ranged from high to low for modafinil and low for clarithromycin. Imprecision influenced our assessment of the certainty of the evidence. </p> </section> </section> <section id="CD012714-sec-0072"> <h3 class="title" id="CD012714-sec-0072">Potential biases in the review process</h3> <p>Two review authors (LMT, RH) have served or currently serve as investigators on RCTs evaluating treatments for idiopathic hypersomnia. In order to minimize the risk of bias related to their involvement in these trials, we prespecified that data extraction and quality assessment would be performed by investigators not involved in a given trial. This was required for the clarithromycin study (<a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a>), but was not necessary for one trial for which data are not yet available (<a href="./references#CD012714-bbs2-0010" title="NCT02512588. A study of safety and efficacy of BTD-001 in treatment of patients with idiopathic hypersomnia (IH) or narcolepsy type 2. clinicaltrials.gov/show/NCT02512588 (first received 31 July 2015). ">NCT02512588</a>). </p> <p>Our use of only subsets of data may have restricted our ability to identify medication benefits. The clarithromycin study analyzed data from 20 participants, consistent with that study's pre‐study power calculation (<a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a>). However, in our review we restricted analysis to only those with idiopathic hypersomnia (50% of the original study population), and then performed parallel‐group rather than cross‐over analyses; both of these prespecified methods reduced our power to detect beneficial or harmful effects of clarithromycin. </p> <p>All of the included studies were relatively small, which limited our ability to identify rare but serious adverse events. Small sample sizes may also have resulted in the finding that neither modafinil nor clarithromycin was more likely than placebo to cause side effects, a finding that is inconsistent with data from larger studies of other conditions. </p> </section> <section id="CD012714-sec-0073"> <h3 class="title" id="CD012714-sec-0073">Agreements and disagreements with other studies or reviews</h3> <p>The American Academy of Sleep Medicine's (AASM) 2021 guideline on the treatment of idiopathic hypersomnia gives a strong recommendation for modafinil (<a href="./references#CD012714-bbs2-0034" title="MaskiK , TrottiLM , KotagalS , AugerRR , RowleyJA , HashmiSD , WatsonNF . Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine in press. [DOI: 10.5664/jcsm.9328]">Maski 2021</a>).  The strong recommendation for modafinil was based on one of the RCTs included here (<a href="./references#CD012714-bbs2-0002" title="MayerG , BenesH , YoungP , BitterlichM , RodenbeckA . Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study. Journal of Sleep Research2015;24(1):74-81. [DOI: 10.1111/jsr.12201] [PMID: 25196321]">Mayer 2015</a>) as well as non‐RCT evidence, and is in agreement with this review that modafinil is effective for the treatment of idiopathic hypersomnia.  </p> <p>The AASM guideline gives a conditional recommendation for the use of clarithromycin (<a href="./references#CD012714-bbs2-0034" title="MaskiK , TrottiLM , KotagalS , AugerRR , RowleyJA , HashmiSD , WatsonNF . Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine in press. [DOI: 10.5664/jcsm.9328]">Maski 2021</a>), based on the RCT included here (<a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a>) as well as non‐RCT evidence.  This is somewhat different than our conclusion that data are insufficient to determine whether clarithromycin is effective for idiopathic hypersomnia, likely reflecting difference in methodology.  For this review, we pre‐specified that we would only analyze the first period of cross‐over studies, limited to only those participants with idiopathic hypersomnia.  In applying this to the <a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a> study, we found no significant difference between clarithromycin and placebo groups, but the reduced sample size and use of only between‐subjects comparisons reduced power to see an effect.  In the AASM guideline, only data from participants with idiopathic hypersomnia were included, but data from both cross‐over periods were considered, allowing within‐subjects comparisons.  The AASM guideline also incorporated non‐RCT evidence.  </p> <p>The original publication of the clarithromycin study reported statistically significant, positive results for our primary outcome, the ESS, with clarithromycin compared to placebo (<a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a>). In the overall cohort of 20 participants, the average reduction in ESS with clarithromycin compared to placebo was four points. In contrast, in our analysis of only the first period of the cross‐over, limited to those 10 participants with idiopathic hypersomnia, we found no significant difference between clarithromycin and placebo groups. Although this might reflect a true difference between participants with idiopathic hypersomnia and those with other hypersomnolence disorders, there was no significant difference in treatment response to ESS based on diagnosis when analyzed in the <a href="./references#CD012714-bbs2-0003" title="TrottiLM , SainiP , BliwiseDL , FreemanAA , JenkinsA , RyeDB . Clarithromycin in gamma-aminobutyric acid-related hypersomnia: a randomized, crossover trial. Annals of Neurology2015;78(3):454-65. [DOI: 10.1002/ana.24459] [PMID: 26094838]">Trotti 2015</a> study, making this less likely. The 95% CI in this review includes the possibilities of meaningful improvement or worsening of ESS with clarithromycin use. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012714-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012714-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#CD012714-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012714-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#CD012714-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012714-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#CD012714-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Modafinil versus placebo, Analysis 1.1: Subjective sleepiness, using Epworth Sleepiness Scale, week 3" data-id="CD012714-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Modafinil versus placebo, <a href="./references#CD012714-fig-0006" title="">Analysis 1.1</a>: Subjective sleepiness, using Epworth Sleepiness Scale, week 3 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#CD012714-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Modafinil versus placebo, Analysis 1.5: Objective sleepiness, using Maintenance of Wakefulness Test, week 3." data-id="CD012714-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Modafinil versus placebo, <a href="./references#CD012714-fig-0010" title="">Analysis 1.5</a>: Objective sleepiness, using Maintenance of Wakefulness Test, week 3. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#CD012714-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Modafinil versus placebo, Outcome 1: Subjective sleepiness, using ESS, week 3" data-id="CD012714-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Modafinil versus placebo, Outcome 1: Subjective sleepiness, using ESS, week 3 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#CD012714-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Modafinil versus placebo, Outcome 2: Other subjective measures of sleepiness or hypersomnia" data-id="CD012714-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Modafinil versus placebo, Outcome 2: Other subjective measures of sleepiness or hypersomnia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#CD012714-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Modafinil versus placebo, Outcome 3: CGI‐S, change from baseline to week 3" data-id="CD012714-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Modafinil versus placebo, Outcome 3: CGI‐S, change from baseline to week 3 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#CD012714-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt='Comparison 1: Modafinil versus placebo, Outcome 4: CGI‐C, "much" or "very much" improved at week 3' data-id="CD012714-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Modafinil versus placebo, Outcome 4: CGI‐C, "much" or "very much" improved at week 3 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#CD012714-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Modafinil versus placebo, Outcome 5: Objective sleepiness, using MWT, week 3" data-id="CD012714-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Modafinil versus placebo, Outcome 5: Objective sleepiness, using MWT, week 3 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#CD012714-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Modafinil versus placebo, Outcome 6: Quality of life or ability to function" data-id="CD012714-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Modafinil versus placebo, Outcome 6: Quality of life or ability to function</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#CD012714-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Modafinil versus placebo, Outcome 7: Adverse events" data-id="CD012714-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Modafinil versus placebo, Outcome 7: Adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#CD012714-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Clarithromycin versus placebo, Outcome 1: Subjective sleepiness, using the ESS" data-id="CD012714-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Clarithromycin versus placebo, Outcome 1: Subjective sleepiness, using the ESS </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#CD012714-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Clarithromycin versus placebo, Outcome 2: Other subjective measures of sleepiness or hypersomnia" data-id="CD012714-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Clarithromycin versus placebo, Outcome 2: Other subjective measures of sleepiness or hypersomnia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#CD012714-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Clarithromycin versus placebo, Outcome 3: Objective sleepiness using the PVT" data-id="CD012714-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Clarithromycin versus placebo, Outcome 3: Objective sleepiness using the PVT </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#CD012714-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Clarithromycin versus placebo, Outcome 4: Quality of life or ability to function" data-id="CD012714-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Clarithromycin versus placebo, Outcome 4: Quality of life or ability to function </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#CD012714-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012714-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/urn:x-wiley:14651858:media:CD012714:CD012714-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Clarithromycin versus placebo, Outcome 5: Adverse events" data-id="CD012714-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_t/tCD012714-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Clarithromycin versus placebo, Outcome 5: Adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#CD012714-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/media/CDSR/CD012714/image_n/nCD012714-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012714-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Modafinil compared to placebo for idiopathic hypersomnia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Modafinil compared to placebo for idiopathic hypersomnia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> idiopathic hypersomnia<br/><b>Setting:</b> outpatient<br/><b>Intervention:</b> modafinil<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What occurs</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Without modafinil</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With modafinil</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Epworth Sleepiness Scale (ESS), week 3<br/>№ of participants: 101<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean ESS at week 3 without modafinil was 15.0.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 5.08 points lower (3.01 lower to 7.16 lower)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modafinil reduces sleepiness as measured by ESS scores.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of naps/week, week 3<br/>№ of participants: 99<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean number of naps/week, week 3 without modafinil was 7.0 naps.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.0 fewer naps<br/>(5.5 fewer to 1.5 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modafinil may reduce the number of naps per week.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical Global Impression ‐ Severity (CGI‐S), change from baseline<br/>№ of participants: 30<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean CGI‐S change from baseline without modafinil was −0.36 points.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 1.02 points lower<br/>(1.93 lower to 0.11 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modafinil probably improves CGI‐S scores.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical Global Impression ‐ Change (CGI‐C), proportion much improved or very much improved at week 3 </p> <p>№ of participants: 70</p> <p>(1 RCT)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 5.14 (1.76 to 15.00)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18.9%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54.5%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35.6% more</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modafinil probably increases the proportion of people who are much improved or very much improved on the CGI‐C. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maintenance of Wakefulness Test (MWT), week 3<br/>№ of participants: 99<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean MWT at week 3 without modafinil was 8.9 minutes.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 4.74 minutes higher<br/>(2.46 higher to 7.01 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modafinil improves the amount of time that participants are able to remain awake during the MWT. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Effectiveness/performance, week 3<br/>№ of participants: 31<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean effectiveness/performance, week 3 without modafinil was 3.28 points.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.68 points lower<br/>(1.26 lower to 0.1 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modafinil probably improves ratings of effectiveness/performance.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of participants with any adverse events<br/>№ of participants: 102<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>OR 1.68 (0.28 to 9.94)</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Modafinil may result in more adverse events.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37.3%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56.9%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.6% more<br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>OR:</b> odds ratio; <b>RCT</b>: randomized controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by two levels for very serious imprecision: confidence interval includes the possibility of harm.<br/><sup>2</sup>Downgraded by one level for imprecision: wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Modafinil compared to placebo for idiopathic hypersomnia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#CD012714-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012714-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Clarithromycin compared to placebo for idiopathic hypersomnia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Clarithromycin compared to placebo for idiopathic hypersomnia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> idiopathic hypersomnia<br/><b>Setting:</b> outpatient<br/><b>Intervention:</b> clarithromycin<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What occurs</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Without clarithromycin</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With clarithromycin</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Epworth Sleepiness Scale (ESS), change from baseline<br/>№ of participants: 10<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean ESS change from baseline without clarithromycin was −1.75 points.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.5 points lower<br/>(5.04 lower to 4.04 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There might be little or no reduction in sleepiness as measured by ESS scores.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stanford Sleepiness Scale (SSS), change from baseline<br/>№ of participants: 10<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean SSS change from baseline without clarithromycin was −1.25 points.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.33 points lower<br/>(2 lower to 1.34 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There might be little or no reduction in sleepiness as measured by SSS scores.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Average nocturnal sleep time from sleep diary, weeks 1 and 2<br/>№ of participants: 10<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean average nocturnal sleep time from sleep diary weeks 1 and 2 without clarithromycin was 462.0 minutes. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 79.7 minutes lower<br/>(171.7 lower to 12.4 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There might be little or no reduction in nocturnal sleep time as measured by sleep diary. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty waking in the morning, average of weeks 1 and 2<br/>№ of participants: 10<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean difficulty waking in the morning average of weeks 1 and 2 without clarithromycin was 5.67 points. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.31 points higher<br/>(2 lower to 2.62 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There might be little or no improvement difficulty waking in the morning as measured by sleep diary. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychomotor vigilance task (PVT) reciprocal of reaction time, change from baseline<br/>№ of participants: 10<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean PVT reciprocal of reaction time change from baseline without clarithromycin was 0.32. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.51 lower<br/>(1.19 lower to 0.17 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There might be little or no change in simple reaction times as measured by PVT reciprocal of reaction time. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functional Outcomes of Sleep Questionnaire (FOSQ), change from baseline<br/>№ of participants: 10<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean FOSQ change from baseline without clarithromycin was 1.62 points.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.79 points higher<br/>(3.02 lower to 4.6 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There might be little or no change in functional impairment due to sleepiness.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of participants with any adverse events<br/>№ of participants: 10<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>OR 0.41<br/>(0.01 to 12.64) </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There might be little difference in adverse events between clarithromycin and placebo.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100.0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83.3%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.7% fewer<br/>(46.5% fewer to 13.2% more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>OR:</b> odds ratio; <b>RCT:</b> randomized controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by two levels for imprecision: confidence interval includes the possibility of harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Clarithromycin compared to placebo for idiopathic hypersomnia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/full#CD012714-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012714-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Modafinil versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Subjective sleepiness, using ESS, week 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.08 [‐7.16, ‐3.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Other subjective measures of sleepiness or hypersomnia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Number of naps/week, week 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.01 [‐5.50, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Duration of daytime sleep per week, week 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.00 [‐81.59, 95.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.3 Exhaustion severity, week 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.67 [‐1.13, ‐0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.4 Nocturnal sleep time (from log), change from baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.98, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 CGI‐S, change from baseline to week 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.02 [‐1.93, ‐0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 CGI‐C, "much" or "very much" improved at week 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.14 [1.76, 15.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Objective sleepiness, using MWT, week 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.74 [2.46, 7.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Quality of life or ability to function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Effectiveness/performance, week 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 Number of participants with any adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.68 [0.28, 9.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 Number of participants who dropped out due to adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.36 [0.13, 85.26]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Modafinil versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#CD012714-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012714-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Clarithromycin versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Subjective sleepiness, using the ESS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 ESS, change from baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Other subjective measures of sleepiness or hypersomnia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 SSS, change from baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Average nocturnal sleep time from sleep diary, weeks 1 and 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.3 Difficulty waking in the morning, average of weeks 1 and 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Objective sleepiness using the PVT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 PVT reciprocal of reaction time, change from baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Quality of life or ability to function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 FOSQ score, change from baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Number of participants with any adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Clarithromycin versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012714.pub2/references#CD012714-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012714.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012714-note-0014">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012714-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012714-note-0012">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD012714-note-0010">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD012714-note-0008">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD012714-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD012714-note-0013">Polski</a> </li> <li class="section-language"> <a class="" href="th#CD012714-note-0007">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD012714-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012714\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012714\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012714\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012714\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012714\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=IregKd2C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012714.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012714.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012714.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012714.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012714.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729366196"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012714.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729366199"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012714.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918edb249b91f4a4',t:'MTc0MDcyOTM2Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 